Drug repurposing and emerging adjunctive treatments for schizophrenia.

Drug repurposing and emerging adjunctive treatments for schizophrenia.

Item
http://www.wikidata.org/entity/Q38417631
Celecoxib Adjunctive Treatment to Antipsychotics in Schizophrenia: A Review of Randomized Clinical Add-On TrialsRepurposing Drugs for Cognition in Schizophrenia.ABC transporters P-gp and Bcrp do not limit the brain uptake of the novel antipsychotic and anticonvulsant drug cannabidiol in miceEditorial (Thematic Selection: Inflammatory and Immune Responses in Depression).The emergence of point-of-care blood-based biomarker testing for psychiatric disorders: enabling personalized medicine.Reduced Slc1a1 expression is associated with neuroinflammation and impaired sensorimotor gating and cognitive performance in mice: Implications for schizophrenia.Kynurenine and Tryptophan Levels in Patients With Schizophrenia and Elevated Antigliadin Immunoglobulin G Antibodies.Characterization of a Novel Mutation in SLC1A1 Associated with Schizophrenia.Autoimmune phenotypes in schizophrenia reveal novel treatment targets.N-Acetylcysteine for the Treatment of Psychiatric Disorders: A Review of Current Evidence
P2860

Drug repurposing and emerging adjunctive treatments for schizophrenia.

Item
http://www.wikidata.org/entity/Q38417631
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Drug repurposing and emerging adjunctive treatments for schizophrenia.
@en
type
label
Drug repurposing and emerging adjunctive treatments for schizophrenia.
@en
prefLabel
Drug repurposing and emerging adjunctive treatments for schizophrenia.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P5875
P698
P921
P356
P1433
P1476
Drug repurposing and emerging adjunctive treatments for schizophrenia.
@en
P2093
P2860
P304
P31
P356
10.1517/14656566.2015.1032248
P407
P433
P478
P577
P5875
P698
P921